Publicaciones en colaboración con investigadores/as de Hospital General Universitario Reina Sofía (70)

2024

  1. Comparative effectiveness and drug survival of biosimilar infliximab CPT-13 vs. reference infliximab in inflammatory bowel disease: A retrospective cohort study

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 6, pp. 553-561

  2. HLA-C*07 is associated with symptomatic HIV-1-associated neurocognitive disorders (HAND) and immune dysregulation

    Infectious Diseases

  3. Intubation Decision Based on Illness Severity and Mortality in COVID-19: An International Study

    Critical care medicine, Vol. 52, Núm. 6, pp. 930-941

  4. Very-Low-Level Viremia, Inflammatory Biomarkers, and Associated Baseline Variables: Three-Year Results of the Randomized TANGO Study

    Open Forum Infectious Diseases, Vol. 11, Núm. 1

2023

  1. A Randomized Trial of Dolutegravir Plus Darunavir/ Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes

    Open Forum Infectious Diseases, Vol. 10, Núm. 11

  2. Correction: Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection (Trials, (2021), 22, 1, (851), 10.1186/s13063-021-05777-6)

    Trials

  3. Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events

    EBioMedicine, Vol. 95, pp. 104773

  4. Failure of Non-Invasive Respiratory Support in Patients with SARS-CoV-2

    Journal of Clinical Medicine, Vol. 12, Núm. 20

  5. IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors

    Frontiers in Immunology, Vol. 14

  6. Impact of proactive therapeutic drug monitoring of infliximab during the induction phase in IBD patients. A Bayesian approach

    Revista Espanola de Enfermedades Digestivas, Vol. 115, Núm. 8, pp. 435-443

  7. Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses

    BMC Infectious Diseases, Vol. 23, Núm. 1

  8. Whole Sequencing and Detailed Analysis of SARS-CoV-2 Genomes in Southeast Spain: Identification of Recurrent Mutations in the 20E (EU1) Variant with Some Clinical Implications

    Diseases, Vol. 11, Núm. 2

2022

  1. Circulating suPAR associates with severity and in-hospital progression of COVID-19

    European Journal of Clinical Investigation, Vol. 52, Núm. 7

  2. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  3. Elevated levels of serum CDCP1 in individuals recovering from severe COVID-19 disease

    Aging, Vol. 14, Núm. 4, pp. 1597-1610

  4. Health impact of COVID pandemic. SESPAS Report 2022

    Gaceta Sanitaria, Vol. 36, pp. S4-S12

  5. Integrase inhibitors in children and adolescents: Clinical use and resistance

    Journal of Antimicrobial Chemotherapy, Vol. 77, Núm. 10, pp. 2784-2792

  6. Saliva changes in composition associated to COVID-19: a preliminary study

    Scientific Reports, Vol. 12, Núm. 1

  7. Salivary ferritin changes in patients with covid-19

    International Journal of Environmental Research and Public Health, Vol. 19, Núm. 1

2021

  1. Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated with the Severity of Coronavirus Disease 2019

    Journal of Infectious Diseases, Vol. 224, Núm. 2, pp. 229-240